On Tuesday, Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), gained 3.38% to $136.78.
BioMarin Pharmaceutical, declared the U.S. Food and Drug Administration (FDA) has accepted for review the submission of a New Drug Application (NDA) for drisapersen for the treatment of Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping, and the Prescription Drug User Fee Act (PDUFA) aim date for a decision is December 27, 2015. The FDA has granted drisapersen Precedingity Review status, which is designated to drugs that offer major advances in treatment, or provide a treatment where no adequate therapy exists.
In the FDA’s filing communication, the Agency informed the company that it is presently planning to hold an advisory committee meeting to talk about the application. No date has been set for this meeting. Drisapersen formerly has been granted Orphan and Fast Track status, in addition to Breakthrough Therapy designations by the FDA. The U.S. filing is based on three randomized placebo-controlled trials and two long-term open-label studies of more than 300 patients in which some boys have been treated for more than three years.
BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally.
Shares of TerraForm Power Inc (NASDAQ:TERP), declined -1.07% to $37.98, during its last trading session.
TerraForm Power Inc, declared the closing of the acquisition of Atlantic Power’s 521-megawatt (MW) portfolio of operating wind power plants.
Concurrent with the closing, SunEdison has formed its second warehouse facility, named TerraForm Private Warehouse, to hold the attained operating assets from Atlantic Power for a maximum period of 7 years. TerraForm Power has an exclusive call right over the warehoused operating assets, and anticipates to add them to the company’s portfolio over time startning with drop downs in the second half of 2016.
TerraForm Power, Inc. owns and operates solar and wind generation assets serving utility, commercial, and residential customers. As of February 20, 2015, its portfolio compriseed of solar and wind projects located in the United States, Canada, the United Kingdom, and Chile with an aggregate nameplate capacity of 1,507.3 megawatt.
At the end of Tuesday’s trade, Shares of Synovus Financial Corp. (NYSE:SNV), gained 0.59% to $30.82.
Synovus Financial Corp. will declare second quarter 2015 results on Tuesday, July 21, 2015. An earnings press release will be published preceding to the earnings conference call, which will start at 8:30 a.m. ET.
A live audio webcast and slides will be accessible with the press release and tables at www.synovus.com/webcasts. A replay will be posted on the company’s website about one hour after the call ends and will be accessible with the press release and slides for 12 months.
Synovus Financial Corporation operates as the bank holding company for Synovus Bank that provides various financial products and services. It offers integrated financial services, counting commercial and retail banking, financial administration, insurance, and mortgage services.
Finally, Marten Transport, Ltd (NASDAQ:MRTN), ended its last trade with 4.83% gain, and close at $21.70.
Marten Transport Ltd., replaced Cracker Barrel Old Country Store in the S&P SmallCap 600 after the close of trading on Wednesday, July 1. Siemens AG is acquiring Dresser-Rand Group in a deal predictable to be accomplished soon.
Cracker Barrel Old Country Store develops and operates the Cracker Barrel Old Country Store concept. Headquartered in Lebanon, TN, the company will be added to the S&P MidCap 400 GICS (Global Industry Classification Standard) Restaurants Sub-Industry index.
Marten Transport, Ltd. operates as a temperature-sensitive truckload carrier for shippers in the United States, Canada, and Mexico. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
